Rahika 150 mg (Capmatinib 150 mg)

Rahika 150 mg, also known as Capmatinib 150 mg, is a type of kinase inhibitor prescribed for the management of metastatic non-small cell lung cancer (NSCLC) in adult patients. It is specifically indicated for individuals whose tumors have a mutation that causes mesenchymal-epithelial transition (MET) exon 14 skipping, as detected by an FDA-approved test.

Capmatinib Dosage:

1.The decision to administer CAPMATINIB should be based on the identification of a mutation that causes MET exon 14 skipping in the patient.

2.The suggested dose for CAPMATINIB is 400 mg taken orally twice a day, with or without food.

Capmatinib package Insert and Capmatinib price in india

The Capmatinib package insert provides important information regarding the administration and monitoring of the medication, while the Capmatinib price may vary in the USA and India depending on factors such as location, insurance coverage, and the pharmaceutical company or distributor.

Capmatinib Side Effects:

• Respiratory issues: CAPMATINIB has the potential to cause lung inflammation, which may be fatal. If you experience new or worsening symptoms such as coughing, fever, or difficulty breathing, contact your healthcare provider immediately.

• Liver problems: CAPMATINIB can lead to abnormal results in liver function tests. Your healthcare provider will conduct these tests prior to and during treatment with CAPMATINIB. Inform your healthcare provider immediately if you experience any indications of liver problems, such as yellowing of the skin or eyes (jaundice), dark or tea-colored urine, light-colored stools, confusion, fatigue, or loss of appetite lasting several days or more.

• Pancreatic issues: CAPMATINIB can increase your blood amylase and/or lipase levels, which may indicate pancreatic issues. Your healthcare provider will conduct pancreatic function tests before and during your treatment with CAPMATINIB. If you experience any indications of pancreatic problems, such as upper abdominal pain that spreads to the back and worsens with eating, weight loss, nausea, or vomiting, notify your healthcare provider immediately.